FDA approves second Alzheimer’s drug that can slow onset of disease

The FDA in the US last Tuesday gave approval to an experimental new drug that has shown to delay the onset of Alzheimer’s disease in trials. Prof Luke O'Neill Professor of Biochemistry at the school of Immunology, Trinity College brought us the details.